Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 01, 2025 12:15 ET | Source: BioPorto A/S

Tildeling af Warrants

1. september 2025 Meddelelse nr. 20 Tildeling af Warrants København, Danmark, den 1. september 2025 (GLOBE NEWSWIRE) –...
September 01, 2025 12:15 ET | Source: BioPorto A/S

Grant of Warrants

September 1, 2025 Announcement no. 20 Grant of Warrants Copenhagen, Denmark, September 1, 2025, (GLOBE NEWSWIRE) – The...
August 28, 2025 06:06 ET | Source: BioPorto A/S

ProNephro AKI™ (NGAL), til tidlig diagnosticering af akut nyreskade, er nu kommercielt tilgængelig på laboratorier i USA gennem BioPortos samarbejde med Roche Diagnostics.

28. august 2025Meddelelse ProNephro AKI™ (NGAL), til tidlig diagnosticering af akut nyreskade, er nu kommercielt tilgængelig på laboratorier i USA gennem BioPortos samarbejde med Roche Diagnostics. ...
August 28, 2025 06:06 ET | Source: BioPorto A/S

ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics.

August 28, 2025News Release ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics. ...
August 15, 2025 01:57 ET | Source: BioPorto A/S

BioPortos delårsresultat for andet kvartal 2025 - Fortsat fremdrift med fuld eksekvering af strategiske mål og stærk NGAL-salgsvækst

15. august 2025Meddelelse nr. 19 BioPortos delårsresultat for andet kvartal 2025 - Fortsat fremdrift med fuld eksekvering af strategiske mål og stærk NGAL-salgsvækst. København, Danmark, 15. august...
August 15, 2025 01:57 ET | Source: BioPorto A/S

BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth.

August 15, 2025Announcement no. 19 BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth. Copenhagen,...
July 29, 2025 09:28 ET | Source: BioPorto A/S

BioPorto A/S afholder webcast for investorer om resultatet for første halvår 2025

29. juli 2025 Meddelelse BioPorto A/S afholder webcast for investorer om resultatet for første halvår 2025 København, Danmark, 29. juli 2025 (GLOBE NEWSWIRE) – BioPorto A/S ("BioPorto" eller...
July 29, 2025 09:28 ET | Source: BioPorto A/S

BioPorto A/S to host an investor webcast on the results for the first half of 2025

July 29, 2025 News release BioPorto A/S to host an investor webcast on the results for the first half of 2025 COPENHAGEN, DENMARK, July 29, 2025 (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or...
July 28, 2025 10:52 ET | Source: BioPorto A/S

BioPorto deltager i Association for Diagnostics & Laboratory Medicine mødet, hvor NGAL og Akut nyreskade vil være et af hovedtemaerne for deltagerne.

28 juli 2025Meddelelse BioPorto deltager i Association for Diagnostics & Laboratory Medicine mødet, hvor NGAL og Akut nyreskade vil være et af hovedtemaerne for deltagerne. Laboratoriemedicin...
July 28, 2025 10:52 ET | Source: BioPorto A/S

BioPorto attends the Association for Diagnostics & Laboratory Medicine meeting, where NGAL and Acute Kidney Injury will be a key focus among participants.

July 28, 2025News Release BioPorto attends the Association for Diagnostics & Laboratory Medicine meeting, where NGAL and Acute Kidney Injury will be a key focus among participants. Laboratory...